HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiziana Casoli Selected Research

Vitamin E Deficiency

6/2004Vitamin E deficiency and aging effect on expression levels of GAP-43 and MAP-2 in selected areas of the brain.
11/2002Decreased expression of glucose transport protein (Glut3) in aging and vitamin E deficiency.
5/2002Morphometric investigations of the mitochondrial damage in ceroid lipopigment accumulation due to vitamin E deficiency.
5/2002Morphometry of age pigment (lipofuscin) and of ceroid pigment deposits associated with vitamin E deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiziana Casoli Research Topics

Disease

14Alzheimer Disease (Alzheimer's Disease)
10/2020 - 11/2002
5Neurodegenerative Diseases (Neurodegenerative Disease)
03/2020 - 06/2006
4Inflammation (Inflammations)
02/2024 - 01/2013
4Vitamin E Deficiency
06/2004 - 05/2002
3Dementia (Dementias)
02/2021 - 01/2019
3Mitochondrial Diseases (Mitochondrial Disease)
01/2015 - 06/2006
3Epilepsy (Aura)
07/2010 - 06/2008
2Cognitive Dysfunction
10/2020 - 04/2014
2Parkinson Disease (Parkinson's Disease)
03/2020 - 02/2020
2Neoplasms (Cancer)
07/2010 - 06/2008
1COVID-19
02/2024
1Frailty
04/2023
1Neurobehavioral Manifestations
10/2020
1Frontotemporal Dementia (Semantic Dementia)
10/2019
1Tauopathies
01/2019
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
03/2014
1Neuroinflammatory Diseases
10/2010
1Traumatic Brain Injuries (Traumatic Brain Injury)
07/2010
1Obesity
07/2010
1Hypoxia (Hypoxemia)
07/2010
1Ischemia
07/2010
1Amyloid Plaque
01/2007

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
02/2024 - 10/2010
6Mitochondrial DNA (mtDNA)IBA
02/2024 - 04/2014
3Amyloid beta-PeptidesIBA
03/2008 - 11/2002
2NucleotidesIBA
02/2024 - 02/2020
2Proteins (Proteins, Gene)FDA Link
02/2021 - 01/2007
2Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2020 - 04/2014
2astaxanthine (astaxanthin)IBA
09/2016 - 01/2016
2Amyloid (Amyloid Fibrils)IBA
01/2013 - 01/2007
2EnzymesIBA
10/2010 - 06/2006
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
05/2008 - 06/2006
2CeroidIBA
05/2002 - 05/2002
1Electron Transport Complex I (NADH-CoQ Reductase)IBA
02/2024
1Interleukin-6 (Interleukin 6)IBA
02/2024
1C-Reactive ProteinIBA
04/2023
1amyloid beta-protein (1-42)IBA
02/2021
1tau Proteins (tau Protein)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Messenger RNA (mRNA)IBA
04/2014
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2014
1LipidsIBA
03/2014
1AntioxidantsIBA
03/2014
1ElementsIBA
01/2013
1Heparin (Liquaemin)FDA LinkGeneric
01/2013
1CytokinesIBA
10/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2010
1Phospholipases (Phospholipase)IBA
10/2010
1Peptides (Polypeptides)IBA
03/2008
1Succinate Dehydrogenase (Fumarate Reductase)IBA
06/2006
1GAP-43 Protein (GAP 43 Protein)IBA
06/2004
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
11/2002
1LipofuscinIBA
05/2002
1lipopigmentsIBA
05/2002

Therapy/Procedure

3Ketogenic Diet
07/2010 - 06/2008
2Cognitive Training
07/2020 - 04/2014
2Therapeutics
07/2010 - 02/2010